Importantly, hyper-expression of GRP78 in patients with head and neck cancers was demonstrated to be correlated with the malignancy levels of several oral diseases, as well as with the malignancy-free survival rates of precancerous oral diseases [84], highly supporting that cell surface GRP78 is a significant molecule for targeting cancer stem cells. This evidence concerns the gene HSPA5 and head and neck cancer.